disulfiram has been researched along with Low Bone Density in 1 studies
Excerpt | Relevance | Reference |
---|---|---|
"We conclude that DSF has a strong osteopenia inducing effect by impairing osteoblast survival and differentiation due to the inhibition of ALDH2 function." | 1.40 | The thiocarbamate disulphide drug, disulfiram induces osteopenia in rats by inhibition of osteoblast function due to suppression of acetaldehyde dehydrogenase activity. ( Baghel, KS; Barbhuyan, TK; Bhadauria, S; Chattopadhyay, N; China, SP; Khan, K; Mittal, M; Pal, S; Porwal, K; Rawat, T; Sanyal, S; Sharma, VL, 2014) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Mittal, M | 1 |
Khan, K | 1 |
Pal, S | 1 |
Porwal, K | 1 |
China, SP | 1 |
Barbhuyan, TK | 1 |
Baghel, KS | 1 |
Rawat, T | 1 |
Sanyal, S | 1 |
Bhadauria, S | 1 |
Sharma, VL | 1 |
Chattopadhyay, N | 1 |
1 other study available for disulfiram and Low Bone Density
Article | Year |
---|---|
The thiocarbamate disulphide drug, disulfiram induces osteopenia in rats by inhibition of osteoblast function due to suppression of acetaldehyde dehydrogenase activity.
Topics: Aldehyde Dehydrogenase; Animals; Apoptosis; Base Sequence; Bone Diseases, Metabolic; Cell Proliferat | 2014 |